Related Experiment Videos
[Further research on the detoxifying effect of RNA]
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|December 1, 1981
Abstract:
Type A Cl. perfringens toxin caused necrosis in guniea-pigs and killed mice. Sodium nucleinate, administered orally to these animals simultaneously with the injection of the toxin and 2 hours later significantly prevented dermonecrosis in guinea-pigs and death in mice, as well as the development of pathomorphological changes in the liver, the kidneys and the spleen, the fatty degeneration of hepatocytes and disturbances in nucleic acid metabolism in these cells.
Insights
Sodium nucleinate protected animals from Clostridium perfringens toxin effects. This compound prevented tissue damage and organ pathology, offering a potential therapeutic strategy against the toxin.
Area of Science:
- Microbiology
- Toxicology
- Pathology
Context:
- Clostridium perfringens toxin Type A is a potent necrotizing agent.
- The toxin induces significant tissue damage and mortality in animal models.
- Pathological changes include liver, kidney, and spleen alterations, with cellular metabolic disturbances.
Purpose:
- To investigate the protective effects of sodium nucleinate against Clostridium perfringens toxin Type A.
- To evaluate the efficacy of sodium nucleinate in preventing toxin-induced dermonecrosis and mortality.
- To assess the impact of sodium nucleinate on toxin-induced pathomorphological and metabolic changes in vital organs.
Summary:
- Sodium nucleinate administration concurrently with or shortly after Clostridium perfringens toxin Type A injection significantly mitigated its harmful effects.
- The compound demonstrated protective capabilities by preventing dermonecrosis in guinea pigs and mortality in mice.
- Furthermore, sodium nucleinate counteracted the development of pathological changes in the liver, kidneys, and spleen, including fatty degeneration of hepatocytes and nucleic acid metabolism disturbances.
Impact:
- Sodium nucleinate shows promise as a potential therapeutic agent against Clostridium perfringens toxin Type A.
- This finding could lead to novel strategies for managing C. perfringens infections and associated toxemia.
- The study highlights the role of nucleic acid metabolism in toxin-induced organ damage and suggests a mechanism for therapeutic intervention.